Rethinking the antibody-dependent enhancement dengue hemorrhagic fever model Date: November 20, 2009 Source: Public Library of Science Summary: New research challenges the dogma of the antibody ...

Research published this week in PLoS Medicine challenges the dogma of the antibody-dependent enhancement model (ADE) for the development of dengue hemorrhagic fever (DHF). Dengue virus infection ...

Research published this week in PLoS Medicine challenges the dogma of the antibody-dependent enhancement model (ADE) for the development of dengue hemorrhagic fever (DHF).

Computer Models Aid Understanding Of Antibody-dependent Enhancement In Spread Of Dengue Fever. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2005 / 10 / 051015092305.htm ...

We must understand the processes that affect transmission--such as antibody-dependent enhancement--to design optimal dengue vaccination strategies," said Donald S. Burke, MD, senior author of the ...

By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus ...

Antibody-dependent enhancement and mosquito-borne viruses. There are hundreds of thousands of dengue cases across the world each year, making dengue viruses one of the most important mosquito ...

Antibodies to dengue may alter course of Zika virus infection ... both cross-neutralization and antibody-dependent enhancement," says Jens Wrammert, PhD, ...

People who are infected a subsequent time with a different type of the dengue virus may experience something called "antibody-dependent enhancement" in which the body's immune response actually ...

A new study finds that people who have antibodies to the mosquito-borne Zika virus are more vulnerable to developing dengue disease. This immune interaction, called antibody-dependent enhancement ...

Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.